Endosomal Transport of ErbB-2: Mechanism for Nuclear Entry of the Cell Surface Receptor
Overview
Authors
Affiliations
The cell membrane receptor ErbB-2 migrates to the nucleus. However, the mechanism of its nuclear translocation is unclear. Here, we report a novel mechanism of its nuclear localization that involves interaction with the transport receptor importin beta1, nuclear pore protein Nup358, and a host of players in endocytic internalization. Knocking down importin beta1 using small interfering RNA oligonucleotides or inactivation of small GTPase Ran by RanQ69L, a dominant-negative mutant of Ran, causes a nuclear transport defect of ErbB-2. Mutation of a putative nuclear localization signal in ErbB-2 destroys its interaction with importin beta1 and arrests nuclear translocation, while inactivation of nuclear export receptor piles up ErbB-2 within the nucleus. Additionally, blocking of internalization by a dominant-negative mutant of dynamin halts its nuclear localization. Thus, the cell membrane-embedded ErbB-2, through endocytosis using the endocytic vesicle as a vehicle, importin beta1 as a driver and Nup358 as a traffic light, migrates from the cell surface to the nucleus. This novel mechanism explains how a receptor tyrosine kinase on the cell surface can be translocated into the nucleus. This pathway may serve as a general mechanism to allow direct communication between cell surface receptors and the nucleus, and our findings thus open a new era in understanding direct trafficking between the cell membrane and nucleus.
Razmi M, Saeednejad Zanjani L, Rahimi M, Sajed R, Safaei S, Madjd Z Cancer Rep (Hoboken). 2024; 7(12):e2133.
PMID: 39610009 PMC: 11604598. DOI: 10.1002/cnr2.2133.
Nuclear EGFR in breast cancer suppresses NK cell recruitment and cytotoxicity.
Escoto A, Hecksel R, Parkinson C, Crane S, Atwell B, King S Oncogene. 2024; 44(5):288-295.
PMID: 39521886 PMC: 11779631. DOI: 10.1038/s41388-024-03211-0.
De Bartolo A, Romeo N, Marrone A, Rago V, Granieri M, Vommaro M Acta Pharmacol Sin. 2024; 46(3):618-631.
PMID: 39414958 PMC: 11845480. DOI: 10.1038/s41401-024-01397-3.
The nuclear export protein exportin-1 in solid malignant tumours: From biology to clinical trials.
Lai C, Xu L, Dai S Clin Transl Med. 2024; 14(5):e1684.
PMID: 38783482 PMC: 11116501. DOI: 10.1002/ctm2.1684.
Decoding how receptor tyrosine kinases (RTKs) mediate nuclear calcium signaling.
Armijos M, Bassani T, Fernandez C, Rodrigues M, Gomes D Adv Biol Regul. 2024; 92:101033.
PMID: 38739986 PMC: 11156257. DOI: 10.1016/j.jbior.2024.101033.